RxDoctor Payments Data

Christopher Fletcher, MD

Hematology · Madison, WINPI 1114121092

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$369,295in research payments, 2019–2025

Across 73 payments — averaging $5058.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Seagen Inc.$212K
  • Adaptive Biotechnologies Corporation$58K
  • AbbVie$54K
  • E.r. Squibb & Sons, L.L.C.$27K
  • Pfizer$19K

How this compares

Too few hematology providers in Wisconsinto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$24,641
Medicare patients
100
Services billed
359

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrukinsaZanubrutinib57$826,172
ImbruvicaIbrutinib12$196,347
RevlimidLenalidomide11$178,345
Acyclovir143$2,170
Famotidine19$145
Prednisone27$102
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$51

Paid to pharmacies, not to this prescriber.

Other hematology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →